Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Membrane of Candida albicans as a target of berberine

BMC Complementary and Alternative MedicineBMC series – open, inclusive and trusted201717:268

Received: 7 November 2016

Accepted: 8 May 2017

Published: 17 May 2017



We investigated the mechanisms of anti-Candida action of isoquinoline alkaloid berberine, active constituent of medically important plants of Barberry species.


The effects on membrane, morphological transition, synthesis of ergosterol and the consequent changes in membrane permeability have been studied. Polarization and lipid peroxidation level of the membrane following berberine treatment have been addressed.


Minimal inhibitory concentration (MIC) of berberine against C. albicans was 17.75 μg/mL. Cytotoxic effect of berberine was concentration dependent, and in sub-MIC concentrations inhibit morphological transition of C. albicans cells to its filamentous form. Results showed that berberine affects synthesis of membrane ergosterol dose-dependently and induces increased membrane permeability causing loss of intracellular material to the outer space (DNA/protein leakage). Berberine also caused membrane depolarization and lipid peroxidation of membrane constituents indicating its direct effect on the membrane. Moreover, ROS levels were also increased following berberine treatment indicating further the possibility of membrane damage.


Based on the obtained results it seems that berberine achieves its anti-Candida activity by affecting the cell membrane.


Berberine Candida albicans Antifungal Membrane


Opportunistic infections in immunocomprised hosts and growing resistance to existing therapeutics have triggered the need for development of new antimicrobial drugs [1].

Isoquinoline alkaloid berberine is present in root, rhizome and stem bark of medically important plants of Barberry species. It has been traditionally used for many years in Ayurvedic and Chinese medicine as antimicrobial agent [2]. Published studies have reported its antibacterial activity against staphylococcal, streptococcal and enterococcal species, including MDR strains of Mycobacterium tuberculosis and MRSA. In vitro studies showed that berberine has activity against clinical isolates of MRSA, with MICs ranging from 32 to 128 μg/mL [3]. Berberine was also effective in protecting mice infected with Salmonella typhimurium: 50% of mice that were not treated with berberine died by the end of the eight day after infection [4]. In combination studies, synergism of berberine was demonstrated with amphotericin [5], fluconazole [6] and miconazole [7] what offers a new approach in the treatment of opportunistic infections resistant to antibiotics. It was reported that berberine loweres MICs of ampicillin and oxacillin against MRSA. Concentrations of 1–50 μg/mL berberine decreased levels of MRSA adhesion and intracellular adhesion compared with the control group [3]. There is also evidence suggesting that bacteria do not develop resistance to berberine since MIC of berberine within same bacterial cultures (E. coli, S. aureus, Bacillus subtilis, Proteus vulgaris, S. typhimurium and P. aeruginosa) did not increase over 200 generations [8]. Efficacy of berberine against Candida species [9, 10] has encouraged us to investigate further its mechanism of action against C. albicans. Namely, nowadays invasive Candida infections are one of the leading causes of mortality in hospitalized and immunocompromised patients. In the present study in vitro techniques have been utilized with the aim to evaluate berberine as a potential antifungal therapeutic and its effects on the membrane and cell wall.



Candida albicans strain ATCC 90028 from stock culture collection of the Department of Microbiology, Faculty of Pharmacy and Biochemistry, University of Zagreb was used for all assays performed.

Berberine preparation

Berberine (chloride form purchased from Sigma, USA) was dissolved in 50% (v/v) ethanol to prepare stock solution (5 μg/mL).

Berberine uptake into C. albicans cells

Intracellular berberine concentration was detected in exponentially growing C. albicans cells [9]. Briefly, cells were harvested, washed twice with PBS (Phosphate-buffered saline), and re-suspended at 5 × 107 cells/mL. Different concentrations of berberine (5, 10, 25, 50 and 100 μg/mL) were added. PBS was added to the control tube (not presented in Fig. 1 since this fluorescence was set as background). One milliliter of each sample was incubated at 37 °C for 15 and 60 min, centrifuged, washed twice with PBS, and re-suspended. OD600 of each sample was adjusted to 0.1 prior to readings. Fluorescence was read in triplicate in 100 μL of each sample from a black 96-well microplate (Greiner, Germany) with a 405 nm excitation and 520 nm emission (Infinite 200 microplate reader, Tecan Group Ltd., Switzerland).

Determination of antifungal susceptibility

The minimum inhibitory concentration of berberine as the lowest concentration giving rise to an inhibition of growth of ≥50% of that of the drug-free control against C. albicans was assessed according to the method reported by Wei and colleagues [7] with minor modifications. Suspension of C. albicans cells was added in sterile flat-bottom 96 well microtiter plate. Serial broth microdilutions of berberine ranging from 256 to 2 μg/mL were added to fungal cells. Plates were incubated aerobically in dark (24 h, 37 °C). Control wells contained 100 μL of cell suspension and berberine solvent. Following incubation XTT (2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-2H–tetrazolium-5-carboxanilide)/menadione solution (0.5 mg/mL XTT and 1 μM menadione (in acetone)) was added for determination of cell viability. Background absorbance was set as dilution of berberine in RPMI 1640 with 2% glucose with addition of XTT/menadione solution. After incubation (2 h, 37 °C) the absorbance was read at 490 nm (iEMS Reader, Labsystem, Finland) and viability of cells was calculated using equitation:% viability = [A490 (treated) - A490 (background)]/A490 (control) × 100.

The test was performed 5 times and results are presented as mean ± SD (N = 5). MIC was calculated using non-linear regression.

Identification of apoptotic and necrotic cells

Viability of C. albicans cells was determined using fluorescent dye exclusion method. The method enables differentiation between viable (intact plasma membrane) and dead cells (damaged plasma membrane) after staining with fluorescent DNA– binding dyes [11]. The assay measures alterations in permeability of individual cell membrane since viable cells exclude ethidium bromide and the appearance of their intact nuclei is bright green. Thus, chromatin in non-viable cells is orange to red colored with organized structure while apoptotic cells are bright green with highly condensed or fragmented nuclei.

In test tubes 100 μL of inoculum suspension (1.5 McFarland units) was mixed with 900 μl of RPMI 1640 with 2% of glucose and different concentrations of berberine (2xMIC, MIC and 1/2xMIC). Amphotericin (1 μg/mL) treated cells served as positive control. The samples were incubated at 35 °C for 3 h. DNA– binding dyes (ethidium bromide and acridine orange) were added to the samples at a final concentration of 100 μg/mL (1:1; v/v). Samples were analysed under fluorescent microscope.

Inhibition of germ-tube formation

The test organism C. albicans was cultured on Sabouraud 2% (w/v) glucose agar (Merck, Germany) for 24 h at 37 °C, aerobically. Inoculum suspension (0.5 McFarland units, nephelometer, bioMerioux, France) for the assay was prepared from fresh culture in physiological saline. The analysis was performed according to the method of Zuzarte et al. [12] with slight modifications. Briefly, test tubes contained 100 μL of inoculum suspension and 900 μL of N-acetyl-D-glucosamine (NAcDG), Leeʾs medium, Spiders medium or yeast-potato-dextrose broth (YPD) + 10% (v/v) foetal bovine serum (FBS) with 17.75, 8.75or 4.375 μg/mL berberine. Negative control contained no cells. The samples were incubated at 35 °C for 5 h. Number of yeast cells with germ-tubes, versus non-germinated cells were determined in Neubauer chamber using phase-contrast microscopy.

Modulation of membrane ergosterol content

The inhibition of ergosterol synthesis was determined in inoculums prepared from fresh cultures of C. albicans with different concentrations of berberine (2xMIC, MIC and 1/2xMIC) according to the method of Kumar and Shukla [13]. Sample treated with voriconazole (4 μg/mL) served as positive control. The samples were incubated at 37 °C for 18 h on orbital shaker (170 rpm) aerobically. Following incubation the cells were harvested by centrifugation (2700×g, 5 min) and the weight of the cell pellet was determined. Freshly prepared alcoholic potassium hydroxide solution (25% m/v, 3 mL) was added to each pellet and vortexed vigorously for 1 min. Obtained cell suspensions were transferred to borosilicate glass tubes and incubated for one hour at 85 °C in a water bath and then allowed to cool. The sterol extraction was enabled by addition of water: n-heptane mixture (1:3 v/v) followed by vortexing (3 min). The produced heptane layer was transferred to a new borosilicate glass tube with screw-cap. Prior to acquisition, 0.6 mL of sterol extract was diluted in 100% ethanol (1:5) and then scanned between 240 and 300 nm at 5 nm intervals (Varian Cary 1 UV-VIS spectrophotometer, Agilent, USA). Characteristic four-peaked curve is indicative for the presence of ergosterol and the late sterol intermediate 24(28) dehydroergosterol (DHE), while the absence of detectable ergosterol in extracts is presented by a flat line. In addition, dose-dependent decrease in the height of the absorbance peaks may be seen and corresponds to a decrease in ergosterol concentration. In our experiments we calculated the ergosterol content as a percentage of the wet weight of the cell using equations:
$$ \begin{array}{c}\hfill \%\mathrm{ergosterol}+\%24(28)\ \mathrm{DHE}=\left[\left({\mathrm{A}}_{281,5}/290\right)\ \mathrm{x}\ \mathrm{F}\right]/\mathrm{cell}\ \mathrm{mass}\hfill \\ {}\hfill \%24(28)\ \mathrm{DHE}=\left[\left({\mathrm{A}}_{230}/518\right)\ \mathrm{x}\ \mathrm{F}\right]/\mathrm{cell}\ \mathrm{mass}\hfill \\ {}\hfill \%\mathrm{ergosterol}=\left[\%\mathrm{ergosterol}+\%24(28)\ \mathrm{DHE}\right]\hbox{-} \%24(28)\ \mathrm{DHE},\hfill \end{array} $$

where F is the factor of sample dilution in ethanol (1:5) and 290 and 518 are the E values (in percentages per centimeter) determined for crystalline ergosterol and 24 (28) DHE, respectively.

Modulation of cell membrane permeability

The effect of berberine on C. albicans cells was further evaluated at the level of cell membrane integrity using the method of Khan and coworkers [14]. To analyze the possible effect of berberine on the cell wall, we tested the releasing of the crucial cell content using spectrophotometric measurement of cell supernatant at 260/280 nm (corresponding to nucleic acids and proteins). Cell suspensions prepared from fresh cultures of C. albicans (2.5 × 107 CFU/mL) were treated with different concentrations of berberine (10xMIC, 2xMIC and MIC) for different time intervals (1 h, 3 h, 6 h, 12 h, and 24 h). Positive control was performed with voriconazole (4 μg/mL). After incubation period, the samples were centrifuged (1250 rpm, 2 min) and the release of cellular material in the supernatants was determined (Biospec Nano, Shimadzu, USA).

Depolarisation of plasma membrane

The effect of berberine treatment on vitality of C. albicans cells was investigated using bis-(1,3-dibutylbarbituric acid) trimethine oxonol [DiBAC4(3)] (Molecular Probes, USA) dye [15]. This method allows monitoring of possible changes in the polarisation state of the cell membrane.

The dye DiBAC4(3) (final concentration 2 μg/mL) was added to the aliquots of cell suspensions (107 CFU/mL) pretreated (60 min) with different concentrations of berberine (1/2xMIC, MIC and 10xMIC).The incubation with the dye lasted 1 h in the dark following washing with PBS. Fluorescence intensity was measured with 488 nm excitation and 510 nm emission (Infinite 200 microplate reader, Tecan Group Ltd., Switzerland).

Determination of lipid peroxidation in whole cell

To determine the level of lipid peroxidation, malondialdehyde (MDA) level was measured by reaction with thiobarbituric acid reactive substances (TBARS) [15]. After treatment with berberine (1/4xMIC, 1/2 × MIC, MIC) for 4 h C. albicans cell suspension was centrifuged (12,000×g, 5 min), the pellet was re-suspended in lyses buffer (2% Triton-X 100, 1% SDS, 100 mM NaCl, 10 mM Tris–HCl, 1 mM EDTA [pH 8.0]) and sonicated on ice. Following centrifugation (12,000×g, 2 min) thiobarbituric acid (TBA, 0.5% w/v) solution in trichloroacetic acid (TCA, 5%) was added (1:1) to the supernatant. The mixture was heated (95 °C, 60 min) and then cooled on ice. Following centrifugation (10,000×g, 10 min, 4 °C) the absorbance of the supernatant fraction was determined at a wavelength of 532 nm and 600 nm. All experiments were done in triplicate. The protein level was determined using BSA as standard [16].

Determination of lipid peroxidation in plasma membrane preparation

To determine the level of lipid peroxidation of plasma membranes of C. albicans cells malondialdehide (MDA) level was measured as described above [15].

Cells were grown in YPD broth containing different concentrations of berberine (1/4 × MIC, 1/2 × MIC, MIC) at 30 °C with shaking. Following cell disruption (homogenizing buffer: 2 mM EDTA, 20% glycerol (v/v), 1 mM phenylmethylsulphonyl fluoride (PMSF) and 50 mM Tris, pH 7.5), homogenate was centrifuged twice (2000×g, 10 min) with washing between. The pelet was resuspended and the plasma membrane fractions were obtained by centrifugation (55,000×g, 45 min). The pellet containing plasma membranes was suspended (20% glycerol v/v, 0.5 mM EDTA, 0.5 mM PMSF, 10 mM HEPES, pH 7.0) and washed once by centrifugation and stored until assay. The protein level was determined using BSA as standard [16].

Measurement of ROS levels

The effect of berberine (1/2xMIC and 1 × MIC) treatment on intracellular ROS levels in C. albicans cells was assessed using the fluorescent dye chloromethyl-dichlorodihydrofluorescein diacetate (CM-H2DCFDA) [17]. Briefly, after treatment with different concentrations of berberine CM-H2DCFDA (final concentration: 20 μM) was added to the cells and incubated (37 °C, 1 h). Fluorescence intensity was measured with a 485 nm excitation and 535 nm emission (Infinite 200 microplate reader, Tecan Group Ltd., Switzerland).

Statistical analysis

The experiments were performed as triplicates at least three times at independent occasions. Results are presented as the mean ± standard deviation where appropriate. Statistical analyses were performed using GraphPad Prism 4.0 software and p < 0.05 was considered statistically significant.


Berberine uptake into C. albicans cells

To test the possible accumulation of berberine inside the C. albicans cells we exposed them to berberine at different concentrations and two time points. The results (Fig. 1) showed an almost linear increment of fluorescence intensity along with dose increase (dose-dependent berberine accumulation). It is also observed that berberine accumulation at a dose 50 μg/mL is time-dependent (augmentation of fluorescence intensity following 60 min- versus 15 min-treatment).
Fig. 1

Fluorescence emitted by berberine sulfate upon intracellular localization in C. albicans cells. The samples were treated with different berberine concentrations for 15 and 60 min. The data are shown as means ± SD

Determination of antifungal susceptibility

Using tetrazolium salt (XTT) reduction assay, the viability of C. albicans cells treated with serial, two-fold dilution of berberine is shown in Fig. 2. Using non-linear regression, drop of viability up to 50% in comparison to the control (untreated) cells was estimated as MIC. Determined MIC value was 17.75 μg/mL.
Fig. 2

Non-linear regression line assessing viability of C. albicans treated with berberine. The data are shown as means ± SD

Identification of apoptotic and necrotic cells

Quantitative fluorescent-dye exclusion test was used to assess cell death of C. albicans treated with berberine in vitro for 3 h. Results of the assay show that berberine significantly (p < 0.05, Pearson chi-square test) reduced cell viability compared to the negative control at all concentrations used (1/2 × MIC; MIC; 2xMIC). (Table 1) The observed effect was concentration dependent (Pearson chi-square test p < 0.05).
Table 1

Results of the quantitative fluorescent assay for simultaneous identification of apoptotic and necrotic cells in C. albicans ATCC 90028 treated with berberine in vitro for 3 h


Viable cells (%)

Non-viable cells


Apoptosis (%)

Necrosis (%)


88.7 ± 2.1

11.3 ± 2.1MIC,2xMIC,NC,PC

7.7 ± 1.5 MIC,2xMIC,PC

3.7 ± 2.52xMIC,PC


75.3 ± 2.5

24.7 ± 2.52xMIC,NC,PC

18.0 ± 1.72xMIC,NC,PC

6.7 ± 1.2NC

2× MIC

62.3 ± 9.7

37.7 ± 9.7NC

28.3 ± 10.3NC

9.3 ± 0.6NC


56.0 ± 4.6

44.0 ± 4.6NC

35.3 ± 2.3NC

8.7 ± 2.5NC


94.7 ± 1.2

5.3 ± 1.2

4.0 ± 1.7

1.3 ± 0.6

300 cells per sample per each experimental point were analysed. Mean values ± SD are shown. MIC minimal inhibitory concentration, PC positive control, NC negative control (RPMI). Statistical significance of data was evaluated using χ2 test. The level of statistical significance was set at P < 0.05. The abbreviations next to the means indicate from which groups the relevant group differs with statistical significance

Inhibition of germ-tube formation

After incubation at 35 °C for 5 h statistically significant (p < 0.05) inhibition of morphological transition of C. albicans cells to its filamentous form was observed for samples treated with two concentrations (1/2 × MIC and1/4 × MIC) of berberine in comparison to the negative control. According to data shown in Fig. 3, the inhibitory effect of berberine at concentration 8.75 μg/mL (¼xMIC) was noticed in media containing NAcDG and Spider’s medium. On the other hand, in Lee’s media and in YPD media with addition of 10% of fetal bovine serum the effect of berberine was less pronounced. The results suggest that berberine affects two different metabolic pathways which regulate budded-to-hypha transition in vitro.
Fig. 3

Effect of different concentrations of berberine on germ tube formation in C. albicans; NC – intact cells. The data are shown as means ± SD

Modulation of membrane ergosterol content

The effect of berberine on the membrane of C. albicans cells was assessed using ergosterol synthesis assay. Figure 4 shows modulation of ergosterol biosynthesis at 1/2 × MIC, MIC and 2xMIC concentration of berberine. Berberine modulates ergosterol content significantly (p < 0.05) in a concentration dependent manner. At the lowest concentration (1/2 × MIC) berberine caused 39% reduction in total sterol content, while two other concentrations produced a reduction of 84 and 87%, respectively.
Fig. 4

Modulation of ergosterol content at different concentration of berberine; PC-voriconazole 4 μg/mL1; NC-intact cells. The data are shown as means ± SD

Modulation of cell membrane permeability

We measured the effect of berberine on cell permeability and integrity of cell membranes. Spectrophotometric measurements of intracellular components that absorb at 260 nm (nucleotides) and 280 nm (protein) in the cell supernatant revealed time- and dose-dependent effect of berberine on the cell membrane permeability. The results show release of intracellular components to the extracellular compartment (Fig. 5). As shown in Fig. 5 berberine, at all concentrations tested, significantly damaged the fungal cell wall within 60 min of treatment causing subsequent increase in DNA/RNA and protein content in extracellular media. Similar trend was observed at other time points with two lower berberine concentrations while the highest berberine concentration (10 × MIC) caused membrane damage within the first hour of treatment. This effect was similar to the effect of voriconazole, which served as positive control. It seems that berberine at highest concentration used, similar to voriconasole, produced maximal possible damage. On the other hand, two lower berberine concentrations reached its plateau of action following 12 h treatment period (there is no further increase in the cellular content outside the cells in following time points assessed and therefore only the last point -24 h - is shown on the graph).
Fig. 5

The effect of berberine on cell permeability and integrity of cell membranes of C. albicans cells. The data are shown as means ± SD

Depolarisation of plasma membrane

We used DiBAC4(3), dye which permeates depolarized cell membranes and binds to intracellular proteins with consequent fluorescence enhancement, to further asses the effect of berberine on the membrane of C. albicans cells. Staining of C. albicans with this dye revealed a significant (p < 0.05) increase in the relative fluorescent units in cell suspensions incubated for 1 h with berberine at all three concentrations (Fig. 6). The effect was dose-dependent (slight increase of relative fluorescent units with a dose increase) although there was no significant change between different concentrations used.
Fig. 6

The effect of different berberine concentrations on membrane depolarisation of C. albicans cells as a measure of membrane damage and cell viability. The data are shown as means ± SDs

Lipid peroxidation levels

Upon the treatment of C. albicans cells with berberine (three different concentrations) the results showed enhancement of lipid peroxidation levels. Moreover, we isolated the membranes of those cells and the peroxidation level of membrane lipids of C. albicans cells showed that berberine up-regulates significantly (p < 0.05) MDA levels in all treated groups (1/4 × MIC, 1/2 × MIC, and MIC).

Level of ROS following berberine treatment in C. albicans

Changes in ROS generation upon berberine treatment of C. albicans cells was assessed using fluorescent molecule CM-H2DCFDA which is sensitive to redox changes. The dye enters the cells and upon deacetylation into dichlorofluorescein emits fluorescence upon oxidation by ROS. Berberine enhanced fluorescence (which reached statistical significance following the treatment with MIC concentration) indicating generation of ROS in treated cells (Fig. 7).
Fig. 7

Lipid peroxidation levels in control and berberine-treated cells of C. albicans and their isolated membranes. Berberine induced dose-dependent increase in TBARS /MDA level as a measure of lipid peroxidation. Cells were treated with berberine (1/4×MIC, ½×MIC and 1×MIC) and the level of lipid peroxidation was assessed in complete cells and membrane preparations. MDA concentration was determined using the TBARS assay. The data are presented as mean values ± SD (*p < 0.01; **p < 0.05; ***p < 0.001).


There is a large gap between needs and available treatments especially in terms of antimicriobial drugs and there are significant efforts to fill this gap with substances of natural origin [1, 2]. One of the hard-to-treat infections is candidiasis and, based on the previous studies [9, 10], our search has been directed to the effectiveness and explanation of mechanisms of action of alkaloid berberine. We show that berberine may enter C. albicans cell (Fig. 1) and may act not only from extracellular site but also inside the fungus cell, having significant antifungal activity against C. albicans with MIC value of 17.75 μg/mL.

C. albicans is a polymorphic fungus and is able to covert to the filamentous form what represents a virulence mechanism which plays an important function in host tissue invasion and resistance to phagocytosis [18]. It has been reported that fungal invasion is facilitated more by the transition between yeast cells and filamentous growth than by yeast growth itself [19]. Morphogenetic transition is a phenomenon which occurs in response to external stimuli including elevated temperature or pH, nitrogen and/or carbon starvation, and the presence of the host macrophages [20]. We tested the effect of berberine against C. albicans in variety of hyphal-inducing media and observed inhibition of filamentation in all media used. However berberine was less effective in YPD media supplemented with 10% FBS suggesting that serum constituents may affect tested compound or interfere with its action. Most prominent berberine effect was observed at subMIC concentration when culturing in NAcDG containing media in which MAPK pathway of morphogenesis is triggered. Berberine also inhibited germ-tube formation of C. albicans cells in sub-MIC concentration in Spider’s medium where the transition is mediated by cAMP-PKA pathway. Namely, inhibition of germ-tube formation of C. albicans by berberine was stronger at sub-MIC concentration in media where MAPK and cAMP-PKA pathways of budded-to-hypha transition are employed. On the other hand, in Lee’s media (Cph2 to Tec1 regulation of hyphal transition) and in yeast-potato-dextrose media with addition of 10% of fetal bovine serum the effect of berberine was less pronounced. This implies the interference of berberine in metabolic pathways what needs further clarification [20].

Anti-Candida activity was assessed with fluorescent-dye exclusion test which enables differentiation between viable blastospores, which exclude ethidium bromide having bright green nuclei with an intact structure, and non-viable cells which have orange to red chromatin with organized structure. Apoptotic cells are bright green with highly condensed or fragmented nuclei [21]. Penetration of ethidium bromide into the cell indicates disruption of the membrane integrity as a possible mechanism of berberine action. Berberine also induced time- and dose- dependent leakage of DNA and proteins from inner to the extracellular space (Fig. 5). Namely, leakage of low molecular weight cytoplasmic components may be an indicator of the membrane disorganization [22]. Similar was noticed for S. agalactiae where berberine induced serious damage of cell membrane and cell wall, and consequently resulted in the reduction of protein materials within the cells [23]. We used anionic lipophilic dye DiBAC4(3) to assess the effect of berberine on the membrane potential as cells at physiological state exclude the dye (negative internal charge) and damaged cells have depolarized membrane and the dye enters the cell, binds to the lipid-rich intracellular components causing increase in the fluorescence. Our experiments showed dose-dependent increase in relative fluorescence units (Fig. 6) in the berberine-treated cells and strengthen our hypothesis on the possible effect of berberine on the activity at cell membrane subsequently leading to the cell death, probably due to apoptosis [17, 24] as indicated in a study on fluconazole-resistant strains [10]. Data presented indicate that berberine may cause apoptosis in C. albicans cells as studies suggest that ROS accumulation induces and/or regulates the induction of apoptosis in yeasts [17, 25].

Ergosterol maintains membrane fluidity and is involved in membrane lipid arrangement. Decrease in its content following berberine treatment may lead to the loss of membrane permeability and thus induce cell vulnerability or even cell death [26, 27].

Using TBARS assay we showed the accumulation of reactive species including hydroxyperoxides and aldehydes, which are indicators of lipid damage [28]. The significant increase of TBARS in berberine treated cells, and specifically in their membrane preparation (Fig. 8), is a sign of an oxidative stress. These results are in line with the analyses of ethidium bromide incorporation into the cells (Table 1). Taken this together with the finding that berberine inhibits ergosterol synthesis (Fig. 4), berberine may have dual effect on the lipid peroxidation of the membrane content. Namely, ergosterol is needed not only for maintenance and regulation of the structural and functional integrity of the fungal membrane but also inhibits lipid peroxidation [29]. Thus, since berberine inhibits ergosterol and induces oxidative stress, it may have aggregated effect on lipid peroxidation levels in Candida cells. This mechanism of berberine action may also explain the permeabilisation of the membrane and the incorporation of ethidium bromide. To further characterize the effect of berberine regarding these events in Candida cells it would be needed to assess activity levels of SOD and catalase as a response and a defense mechanism at enhanced ROS levels [14, 17, 27, 30]. Namely, all organisms/cells are permanently affected by reactive oxygen and nitrogen species but oxidative stress and its consequences occur only when the cell is not able to overcome its „overload“[31]. C albicans plasma membrane is composed of app 70% polyunsaturated lipids [32]. High level of lipid peroxidation products following different noxious is predictable [11, 33]. Moreover, lipid peroxidation may lead to the functional and functional changes of the plasma membrane, and at higher extent, to the cell death [24, 27, 34]. In addition, Dhamgaye and colleagues [9] showed that berberine treatment results in dysfunctional mitochondria, which was evident from its slow growth in non-fermentative carbon source. They also showed poor labeling of treated cells with mitochondrial membrane potential sensitive probe [9] confirming further possible use of berberine as antifungal drug.
Fig. 8

Changes in ROS generation upon berberine treatment of C. albicans cells. Berberine at sub MIC concentration induced ROS production. The augmentation of ROS production reached statistical significance upon the treatment with MIC concentration of berberine. The data are presented as mean values ± SD (*p < 0.05).

Our findings suggest that berberine may change sterol profile of yeast by causing inhibition of ergosterol biosynthesis. Berberine also induces lipid peroxidation which may be one of the mechanisms involved in its Candida-cidal activity.


Based on the results presented, we conclude that berberine induces mechanisms involved in its Candida-cidal activity probably mainly at the level of the cell membrane. Therefore it seems that berberine may serve as an alternative for the treatment and/or prevention of candidiasis.



American type culture collection


Bicinchoninic acid


Colony-forming unit


2′,7′-Dichlorodihydrofluorescein diacetate




Bis-(1,3-Dibarbituric acid)-trimethine oxanol


Deoxyribonucleic acid


Ethylenediaminetetraacetic acid


European committee on antimicrobial susceptibility testing


Fetal bovine serum


(4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid






Minimum inhibitory concentration


Methicillin-resistant Staphylococcus aureus




Phosphate-buffered saline


phenylmethylsulphonyl fluoride


Reactive oxygen species


Roswell park memorial institute


Superoxide dismutase


Thiobarbituric acid reactive species


Trichloroacetic acid


2,3-Bis-(2-methoxy-4-nitro-5-sulfophenyl)-2H–tetrazolium-5-carboxanilide salt


Yeast potato dextrose



Authors are thankful to Mrs. Stefica Babic for technical assistance. Valuable help of Mr. Jake Raguz, native English speaker, is appreciated.


No funding.

Availability of data and materials

The datasets supporting the conclusions of this article are presented in the paper.

Authors’ contributions

NZ, IB, MJ and JV carried out the study; IK and JV designed the experiments and wrote the manuscript; IK and ST supervised the work; IK provided the yeast strain; all authors read and approved the final manuscript.

Competing interests

The authors declare that they have no competing interests.

Consent for publication

Not applicable in this section.

Ethics approval and consent to participate

Not applicable in this section.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (, which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

Agency for Medicinal Products and Medical Devices of Croatia
University of Zagreb, Faculty of Pharmacy and Biochemistry
Department of Molecular Medicine, Ruđer Bošković Institute


  1. Roser E, Gründemann C, Engels I, Huber R. Antibacterial in vitro effects of preparations from Anthroposophical medicine. BMC Complement Altern Med. 2016; doi:
  2. Blumenthal M. The complete German commission E monographs - therapeutic guide to herbal medicine. Austin, TX: American Botanical Council; 1998.Google Scholar
  3. Yu HH, Kim KJ, Cha JD, Kim HK, Lee YE, Choi NY, You YOJ. Antimicrobial activity of berberine alone and in combination with ampicillin or oxacillin against methicillin-resistant Staphylococcus aureus. Med Food. 2005; doi:
  4. Chu M, Xiao R, Yin Y, Wang X, Chu Z, Zhang M, Ding R, Wang Y. Berberine: a medicinal compound for the treatment of bacterial infections. Clin Microbial. 2014; doi:
  5. Han Y, Lee JH. Berberine synergy with amphotericin B against disseminated candidiasis in mice. Biol Pharm Bull. 2005;28(3):541–4.View ArticlePubMedGoogle Scholar
  6. Quan H, Cao YY, Xu Z, Zhao JX, Gao PX, Qin XF, Jiang YY. Potent in vitro synergism of fluconazole and berberine chloride against clinical isolates of Candida albicans resistant to fluconazole. Antimicrob Agents Chemother. 2006; doi:
  7. Wei GX, Xu X, Wu CD. In vitro synergism between berberine and miconazole against planktonic and biofilm Candida cultures. Arch Oral Biol. 2011; doi:
  8. Jin J, Hua G, Meng Z, Gao P. Antibacterial mechanisms of berberine and reasons for little resistance of bacteria. Chin Herb Med. 2011; doi:
  9. Dhamgaye S, Devaux F, Vandeputte P, Khandelwal NK, Sanglard D, Mukhopadhyay G, Prasad R. Molecular mechanisms of action of herbal antifungal alkaloid berberine in Candida albicans. PloS ONE. 2014. doi:
  10. da Silva AR, de Andrade Neto JB, da Silva CR, Campos RDS, Costa Silva RA, Freitas DD, do Nascimento FBSA, de Andrade LND, Sampaio LS, Grangeiro TB, Magalhães HIF, Cavalcanti BC, de Moraes MO, Nobre Júnior HV. Berberine antifungal activity in fluconazole-resistant pathogenic yeasts: action mechanism evaluated by flow cytometry and biofilm growth inhibition in Candida spp. Antimicrob Agents Chemother. 2016. doi:
  11. Zorić N, Horvat I, Kopjar N, Vučemilović A. Kremer, Tomić S, Kosalec I. Hydroxytyrosol expresses antifungal activity in vitro. Curr Drug Targets. 2013;14:992–8.View ArticlePubMedGoogle Scholar
  12. Zuzarte M, Vale-Silva L, Gonçalves MJ, Cavaleiro C, Vaz S, Canhoto J, Pinto E, Salgueiro L. Antifungal activity of phenolic-rich Lavandula multifida L. essential oil. Eur J Clin Microbiol Infect Dis. 2012. doi:
  13. Kumar R, Shukla PK. Amphotericin B resistance leads to enhanced proteinase and phospholipase activity and reduced germ tube formation in Candida albicans. Fungal Biol. 2010; doi:
  14. Khan MSA, Ahmad I, Cameotra SS. Phenyl aldehyde and propanoids exert multiple sites of action towards cell membrane and cell wall targeting ergosterol in Candida albicans. AMB Express. 2013; doi:
  15. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951;193(1):265–75.PubMedGoogle Scholar
  16. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem. 1979; doi:
  17. Cho J, Lee DG. The antimicrobial peptide arenicin-1 promotes generation of reactive oxygen species and induction of apoptosis. Biochim Biophys Acta. 2011; doi:
  18. Jayatilake JA, Samaranayake YH, Cheung LK, Samaranayake LP. Quantitative evaluation of tissue invasion by wild type, hyphal and SAP mutants of Candida albicans, and non-albicans Candida species in reconstituted human oral epithelium. J Oral Pathol Med. 2006; doi:
  19. Cullen PJ, Sprague GF Jr. The regulation of filamentous growth in yeast. Genetics. 2012; doi:
  20. Midkiff J, Borochoff-Porte N, White D, Johnson DI. Small molecule inhibitors of the Candida albicans budded-to-hyphal transition act through multiple signaling pathways. PLoS One. 2011; doi:
  21. Kosalec I, Puel O, Delaforge M, Kopjar N, Antolovic R, Jelic D, Matica B, Galtier P, Pepeljnjak S. Isolation and cytotoxicity of low-molecular-weight metabolites of Candida albicans. Front Biosci. 2008;13:6893–904.View ArticlePubMedGoogle Scholar
  22. Hitchcock PJ, Brown TM. Morphological heterogeneity among Salmonella lipopolysaccharide chemotypes in silver-stained polyacrylamide gels. J Bacteriol. 1983;154(1):269–77.PubMedPubMed CentralGoogle Scholar
  23. Peng B, Li H, Peng XX. Functional metabolomics: from biomarker discovery and metabolome reprogramming. Protein Cell. 2015; doi:
  24. Liao S, Klein MI, Heim KP, Fan Y, Bitoun JP, Ahn SJ, Burne RA, Koo H, Brady LJ, Wen ZT. Streptococcus mutans extracellular DNA is upregulated during growth in biofilms, actively released via membrane vesicles, and influenced by components of the protein secretion machinery. J Bacteriol. 2014;196:2355–66.View ArticlePubMedPubMed CentralGoogle Scholar
  25. Lee H, Hwang JS, Lee DG. Scolopendin 2 leads to cellular stress response in Candida albicans. Apoptosis. 2016; doi:
  26. Aikens J, Dix TA. Hydrodioxyl (perhydroxyl), peroxyl, and hydroxyl radical-initiated lipid peroxidation of large unilamellar vesicles (liposomes): comparative and mechanistic studies. Arch Biochem Biophys. 1993;395:516–25.View ArticleGoogle Scholar
  27. Khan A, Ahmad A, Akhtar F, Yousuf S, Xess I, Khan LA, Manzoor N. Induction of oxidative stress as a possible mechanism of the antifungal action of three phenylpropanoids. FEMS Yeast Res. 2010; doi:
  28. Janero DR. Malondialdehyde and thiobarbituric acid-reactivity as diagnostic indices of lipid peroxidation and peroxidative tissue injury. Free Radic Biol Med. 1990;9(6):515–40.View ArticlePubMedGoogle Scholar
  29. Khan H, Saeed M, Khan MA, Khan I, Ahmad M. Muhammad N, Khan A. Antimalarial and free radical scavenging activities of rhizomes of Polygonatum verticillatum supported by isolated metabolites. Med Chem Res 2011. doi:
  30. Missall TA, Lodge JK, McEwen JE. Mechanisms of resistance to oxidative and nitrosative stress: implications for fungal survival in mammalian hosts. Eukaryot Cell. 2004;3:835–46.View ArticlePubMedPubMed CentralGoogle Scholar
  31. Jazvinšćak Jembrek M, Vlainić J, Radovanović J, Radovanović V, Erhardt J, Oršolić N. Effects of copper overload in P19 neurons: impairment of glutathione redox homeostasis and crosstalk between caspase and calpain protease systems in ROS-induced apoptosis. Biometals. 2014; doi:
  32. Georgopapadakou NH, Dix BA, Smith SA, Freudenberger J, Funke PT. Effect of antifungal agents on lipid biosynthesis and membrane integrity in Candida albicans. Antimicrob Agents Chemother. 1987;31(1):46–51.View ArticlePubMedPubMed CentralGoogle Scholar
  33. Shao J, Shi G, Wang T, Wu D, Wang C. Antiproliferation of Berberine in combination with Fluconazole from the perspectives of reactive oxygen species, Ergosterol and drug efflux in a Fluconazole-resistant Candida tropicalisIsolate. Front Microbiol. 2016;7:1516.View ArticlePubMedPubMed CentralGoogle Scholar
  34. Ahmad A, Khan A, Kumar P, Bhatt RP, Manzoor N. Antifungal activity of Coriaria nepalensis essential oil by disrupting ergosterol biosynthesis and membrane integrity against Candida. Yeast. 2011; doi:


© The Author(s). 2017